Business
Adult ADHD: What you need to know
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood, and it’s usually diagnosed in kids. But...
US deficit: Bill Gross warns Trump would be ‘more disruptive’ for the bond market
If Donald Trump returns to the White House, it would worsen budget deficits and the bond market would suffer more...
AI skills in these non-tech professions come with massive wage increases
On average, U.S. workers with artificial intelligence skills command a wage premium of up to 25%, but some jobs can...
Housing market outlook: Buyers are gaining the upper hand
The U.S. housing market is now tilting in favor of buyers, who are pushing back against the high home prices...
Qatar Airways flight hits severe turbulence over Turkey, injuring 12 passengers, but lands as scheduled in Dublin
A Qatar Airways flight encountered severe turbulence over Turkey, injuring 12 people on board, before landing as scheduled Sunday in...
Joseph Stiglitz interview: Columbia economics professor and Nobel laureate
Stiglitz says the protest movement gripping his institution and many others “does hit home” and recalled his own history as...
Entering the ‘amenities arms race’ at luxury apartments: IV drips and Botox without having to leave your home
Rental residents used to be content with a nice pool, free lobby coffee, and even valet trash service. But the...
Ferrari 296 GTS Hybrid Review: ‘Arresting, uncanny beauty’ with $366,139 price tag
Don’t make the mistake of patronizing the Ferrari 296 GTS. I know it’s tempting, because this $366,139 centerfold packs a...
Deficit warning: Yellen says higher rates make managing it harder
Treasury Secretary Janet Yellen said the outlook for higher interest rates over the long haul makes it tougher to contain...
Could drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential longevity pills
It’s the question many scientists are asking about the controversial drug, a glucagon-like peptide-1 receptor agonist (GLP-1), as some research...
What's New Here!
